{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:33:52Z","timestamp":1780662832461,"version":"3.54.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Immunology and Immunopathology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.vetimm.2019.109996","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T08:42:35Z","timestamp":1576485755000},"page":"109996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Identification of the JAK-STAT pathway in canine splenic hemangiosarcoma, thyroid carcinoma, mast cell tumor, and anal sac adenocarcinoma"],"prefix":"10.1016","volume":"220","author":[{"given":"Erin","family":"Cletzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawna","family":"Klahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Dervisis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"LeRoith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vetimm.2019.109996_bib0005","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1126\/science.1071545","article-title":"A road map for those who don\u2019t know JAK-STAT","volume":"296","author":"Aaronson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.vetimm.2019.109996_bib0010","doi-asserted-by":"crossref","first-page":"e0176181","DOI":"10.1371\/journal.pone.0176181","article-title":"Loss of function JAK1 mutations occur at high frequency in cancers with microsatellite instability and are suggestive of immune evasion","volume":"12","author":"Albacker","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.vetimm.2019.109996_bib0015","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/leu.2017.252","article-title":"Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling","volume":"32","author":"Andersson","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.vetimm.2019.109996_bib0020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/jvim.14860","article-title":"STAT3 expression and activity are up-regulated in diffuse large B cell lymphoma of dogs","volume":"32","author":"Assumpcao","year":"2018","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.vetimm.2019.109996_bib0025","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/bjh.14803","article-title":"Preclinical evaluation of the BET bromodomain inhibitor BAY 1238097 for the treatment of lymphoma","volume":"178","author":"Bernasconi","year":"2017","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.vetimm.2019.109996_bib0030","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.exphem.2011.02.003","article-title":"Identification of JAK2 mutations in canine primary polycythemia","volume":"39","author":"Beurlet","year":"2011","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.vetimm.2019.109996_bib0035","first-page":"e23828","article-title":"Targeting the tumor microenvironment: JAK-STAT3 signaling","volume":"2","author":"Bournazou","year":"2013","journal-title":"Jakstat"},{"key":"10.1016\/j.vetimm.2019.109996_bib0040","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12917-015-0505-7","article-title":"Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinoma","volume":"11","author":"Brown","year":"2015","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.vetimm.2019.109996_bib0045","first-page":"e27638","article-title":"IL-4, JAK-STAT signaling, and pain","volume":"2","author":"Busch-Dienstfertig","year":"2013","journal-title":"Jakstat"},{"key":"10.1016\/j.vetimm.2019.109996_bib0050","doi-asserted-by":"crossref","first-page":"106753","DOI":"10.18632\/oncotarget.22053","article-title":"The effect of the JAK2 inhibitor TG101209 against T cell acute lymphoblastic leukemia (T-ALL) is mediated by inhibition of JAK-STAT signaling and activation of the crosstalk between apoptosis and autophagy signaling","volume":"8","author":"Cheng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.vetimm.2019.109996_bib0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020188","article-title":"Dynamics of the STAT3 transcription factor: nuclear import dependent on Ran and importin-beta1","volume":"6","author":"Cimica","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vetimm.2019.109996_bib0060","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/1746-6148-8-244","article-title":"Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell lines","volume":"8","author":"Couto","year":"2012","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.vetimm.2019.109996_bib0065","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.277.5332.1630","article-title":"STATs and gene regulation","volume":"277","author":"Darnell","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.vetimm.2019.109996_bib0070","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.canlet.2017.06.016","article-title":"Anti-myeloma effects of ruxolitinib combined with bortezomib and lenalidomide: a rationale for JAK\/STAT pathway inhibition in myeloma patients","volume":"403","author":"de Oliveira","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.vetimm.2019.109996_bib0075","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1471-2407-11-125","article-title":"Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines","volume":"11","author":"Fossey","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.vetimm.2019.109996_bib0080","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1471-2407-11-112","article-title":"The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines","volume":"11","author":"Fossey","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.vetimm.2019.109996_bib0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1471-2407-9-81","article-title":"Characterization of STAT3 activation and expression in canine and human osteosarcoma","volume":"9","author":"Fossey","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.vetimm.2019.109996_bib0090","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jaut.2017.06.006","article-title":"Small molecules to the rescue: inhibition of cytokine signaling in immune-mediated diseases","volume":"85","author":"Gadina","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.vetimm.2019.109996_bib0095","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1038\/sj.onc.1204349","article-title":"Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells","volume":"20","author":"Garcia","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.vetimm.2019.109996_bib0100","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.1128\/MCB.00613-07","article-title":"Amino acid residues required for physical and cooperative transcriptional interaction of STAT3 and AP-1 proteins c-Jun and c-Fos","volume":"27","author":"Ginsberg","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.vetimm.2019.109996_bib0105","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/jvp.12101","article-title":"Oclacitinib (APOQUEL((R))) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy","volume":"37","author":"Gonzales","year":"2014","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.vetimm.2019.109996_bib0110","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1080\/14656566.2017.1404574","article-title":"The BCR-ABL1-negative myeloproliferative neoplasms: a review of JAK inhibitors in the therapeutic armamentarium","volume":"18","author":"Griesshammer","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.vetimm.2019.109996_bib0115","doi-asserted-by":"crossref","first-page":"10188","DOI":"10.1073\/pnas.96.18.10188","article-title":"A nuclear protein tyrosine phosphatase is required for the inactivation of Stat1","volume":"96","author":"Haspel","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vetimm.2019.109996_bib0120","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijcard.2015.05.152","article-title":"Sodium tanshinone IIA sulfonate ameliorates ischemia-induced myocardial inflammation and lipid accumulation in Beagle dogs through NLRP3 inflammasome","volume":"196","author":"Hu","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.vetimm.2019.109996_bib0125","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1177\/0300985814559400","article-title":"Estrogen receptor and signal transducer and activator of transcription 3 expression in equine mammary tumors","volume":"52","author":"Hughes","year":"2015","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.vetimm.2019.109996_bib0130","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1097-2765(01)00199-X","article-title":"Cooperation between STAT3 and c-jun suppresses Fas transcription","volume":"7","author":"Ivanov","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.vetimm.2019.109996_bib0135","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/S2352-3026(16)30194-6","article-title":"Ruxolitinib for symptom control in patients with chronic lymphocytic leukaemia: a single-group, phase 2 trial","volume":"4","author":"Jain","year":"2017","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.vetimm.2019.109996_bib0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189670","article-title":"The JAK2\/STAT3 inhibitor pacritinib effectively inhibits patient-derived GBM brain tumor initiating cells in vitro and when used in combination with temozolomide increases survival in an orthotopic xenograft model","volume":"12","author":"Jensen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.vetimm.2019.109996_bib0145","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1158\/1078-0432.CCR-07-4839","article-title":"Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers","volume":"14","author":"Jeong","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.vetimm.2019.109996_bib0150","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/vco.12311","article-title":"The JAK2\/STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma","volume":"16","author":"Keller","year":"2017","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.vetimm.2019.109996_bib0155","first-page":"3692","article-title":"Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma","volume":"9","author":"Khoury","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.vetimm.2019.109996_bib0160","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s12272-016-0795-8","article-title":"Signal transducer and activator of transcription 3 as a therapeutic target for cancer and the tumor microenvironment","volume":"39","author":"Kim","year":"2016","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.vetimm.2019.109996_bib0165","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/08977194.2012.660936","article-title":"Biology and significance of the JAK\/STAT signalling pathways","volume":"30","author":"Kiu","year":"2012","journal-title":"Growth Factors"},{"key":"10.1016\/j.vetimm.2019.109996_bib0170","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11259-011-9489-3","article-title":"Density of Gr1-positive myeloid precursor cells, p-STAT3 expression and gene expression pattern in canine mammary cancer metastasis","volume":"35","author":"Krol","year":"2011","journal-title":"Vet. Res. Commun."},{"key":"10.1016\/j.vetimm.2019.109996_bib0175","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jcpa.2016.05.016","article-title":"Is STAT3 and PTEN Expression Altered in Canine Prostate Cancer?","volume":"155","author":"Lin","year":"2016","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.vetimm.2019.109996_bib0180","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1476-5829.2011.00275.x","article-title":"Preliminary evidence for biologic activity of toceranib phosphate (Palladia((R))) in solid tumours","volume":"10","author":"London","year":"2012","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.vetimm.2019.109996_bib0185","first-page":"2755","article-title":"Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies","volume":"9","author":"London","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.vetimm.2019.109996_bib0190","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1111\/jvim.14837","article-title":"JAK1\/2 inhibitors AZD1480 and CYT387 inhibit canine B-cell lymphoma growth by increasing apoptosis and disrupting cell proliferation","volume":"31","author":"Lu","year":"2017","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.vetimm.2019.109996_bib0195","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1002\/ijc.24660","article-title":"The novel HSP90 inhibitor STA-1474 exhibits biologic activity against osteosarcoma cell lines","volume":"125","author":"McCleese","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.vetimm.2019.109996_bib0200","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1073\/pnas.91.6.2285","article-title":"Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130","volume":"91","author":"Narazaki","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vetimm.2019.109996_bib0205","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-med-051113-024537","article-title":"The JAK-STAT pathway: impact on human disease and therapeutic intervention","volume":"66","author":"O\u2019Shea","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.vetimm.2019.109996_bib0210","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcpa.2005.07.005","article-title":"Immunohistochemical study of STAT3 expression in feline injection-site fibrosarcomas","volume":"134","author":"Petterino","year":"2006","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.vetimm.2019.109996_bib0215","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11259-006-3330-4","article-title":"Immunohistochemical study of phospho-Stat3-ser727 expression in feline mammary gland tumours","volume":"31","author":"Petterino","year":"2007","journal-title":"Vet. Res. Commun."},{"key":"10.1016\/j.vetimm.2019.109996_bib0220","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11259-006-3335-z","article-title":"Expression of Stat3 in feline mammary gland tumours and its relation to histological grade","volume":"30","author":"Petterino","year":"2006","journal-title":"Vet. Res. Commun."},{"key":"10.1016\/j.vetimm.2019.109996_bib0225","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.rvsc.2006.06.010","article-title":"Immunohistochemical evaluation of STAT3-p-tyr705 expression in feline mammary gland tumours and correlation with histologic grade","volume":"82","author":"Petterino","year":"2007","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.vetimm.2019.109996_bib0230","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.rvsc.2005.05.009","article-title":"Immunodetection of the signal transducer and activator of transcription-3 in canine haemangioma and haemangiosarcoma","volume":"80","author":"Petterino","year":"2006","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.vetimm.2019.109996_bib0235","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1242\/jcs.00963","article-title":"The JAK\/STAT signaling pathway","volume":"117","author":"Rawlings","year":"2004","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.vetimm.2019.109996_bib0240","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0092-8674(00)81166-6","article-title":"Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses","volume":"93","author":"Rodig","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.vetimm.2019.109996_bib0245","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/jor.21088","article-title":"Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated-Stat3 correlates with poor prognosis","volume":"28","author":"Ryu","year":"2010","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.vetimm.2019.109996_bib0250","doi-asserted-by":"crossref","first-page":"41893","DOI":"10.1074\/jbc.C500358200","article-title":"JAK1 and Tyk2 activation by the homologous polycythemia vera JAK2 V617F mutation: cross-talk with IGF1 receptor","volume":"280","author":"Staerk","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vetimm.2019.109996_bib0255","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.tvjl.2012.01.033","article-title":"Overexpression of P-glycoprotein, STAT3, phospho-STAT3 and KIT in spontaneous canine cutaneous mast cell tumours before and after prednisolone treatment","volume":"193","author":"Teng","year":"2012","journal-title":"Vet. J."},{"key":"10.1016\/j.vetimm.2019.109996_bib0260","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/CMR.0b013e328331ca86","article-title":"RT-PCR-based tyrosine kinase display profiling of canine melanoma: IGF-1 receptor as a potential therapeutic target","volume":"20","author":"Thamm","year":"2010","journal-title":"Melanoma Res."},{"key":"10.1016\/j.vetimm.2019.109996_bib0265","doi-asserted-by":"crossref","first-page":"6613","DOI":"10.1038\/sj.onc.1204086","article-title":"STAT proteins: novel molecular targets for cancer drug discovery","volume":"19","author":"Turkson","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.vetimm.2019.109996_bib0270","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0739-7240(01)00088-1","article-title":"Growth hormone induces tyrosyl phosphorylation of the transcription factors Stat5a and Stat5b in CMT-U335 canine mammary tumor cells","volume":"20","author":"van Garderen","year":"2001","journal-title":"Domest. Anim. Endocrinol."},{"key":"10.1016\/j.vetimm.2019.109996_bib0275","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13045-016-0367-x","article-title":"Phase 1\/2 study of pacritinib, a next generation JAK2\/FLT3 inhibitor, in myelofibrosis or other myeloid malignancies","volume":"9","author":"Verstovsek","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.vetimm.2019.109996_bib0280","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/gb-2004-5-12-253","article-title":"The Janus kinases (Jaks)","volume":"5","author":"Yamaoka","year":"2004","journal-title":"Genome Biol."}],"container-title":["Veterinary Immunology and Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242719302363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242719302363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:27:14Z","timestamp":1759044434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165242719302363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":56,"alternative-id":["S0165242719302363"],"URL":"https:\/\/doi.org\/10.1016\/j.vetimm.2019.109996","relation":{},"ISSN":["0165-2427"],"issn-type":[{"value":"0165-2427","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of the JAK-STAT pathway in canine splenic hemangiosarcoma, thyroid carcinoma, mast cell tumor, and anal sac adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Veterinary Immunology and Immunopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vetimm.2019.109996","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109996"}}